L. Fu, G. W. Gribble / Tetrahedron Letters 48 (2007) 9155–9158
9157
Calcd for C12H12N2O3S: C, 54.53; H, 4.58; N, 10.60; S,
12.13. Found: C, 54.27; H, 4.58; N, 10.48; S, 12.28.
Compound 3a: white solid; mp 169–170.5 °C; 1H NMR
(CDCl3): d 7.84–7.86 (m, 2H), 7.81 (br s, 1H), 7.45–7.53 (m,
3H), 7.32 (t, 1H,), 6.49 (t, 1H,), 6.05 (dd, 1H, J), 3.65 (s,
3H); 13C NMR (CDCl3): d 164.6, 135.1, 131.6, 128.9, 127.1,
122.8, 120.0, 113.5, 100.7, 36.8; Anal. Calcd for
C12H12N2O: C, 71.98; H, 6.04; N, 13.99. Found: C, 71.92;
H, 6.06; N, 14.02.
Acknowledgments
This work was supported by the Donors of the Petro-
leum Research Fund (PRF), administrated by the Amer-
ican Chemical Society, and by Wyeth.
References and notes
Compound 3b: white solid; mp 170.5–172 °C; 1H NMR
(CDCl3): d 7.90–7.92 (m, 2H), 7.85 (t, 1H), 7.80–7.82 (m,
3H), 7.45–7.60 (m, 6H), 7.14 (dd, 1H), 6.32 (dd, 1H); 13C
NMR (CDCl3): d 165.0, 138.9, 134.2, 134.1, 132.2, 129.7,
129.1, 127.2, 127.1, 127.0, 120.0, 110.3, 107.7; Anal. Calcd
for C17H14N2O3S: C, 62.56; H, 4.32; N, 8.58; S, 9.83.
Found: C, 62.40; H, 4.28; N, 8.56; S, 9.90.
1. Pyrrole-based heterocycles: (a) Grehn, L. Chem. Scripta
1980, 16, 77–84; (b) Grehn, L. Chem. Scripta 1980, 16, 85–
96; (c) Wu, J.; Vetter, W.; Gribble, G. W.; Schneekloth, J.
S., Jr.; Blank, D. H.; Gorls, H. Angew. Chem., Int. Ed. 2002,
41, 1740–1743.
2. Pyrrole-based drugs: (a) Baraldi, P. G.; Preti, D.; Frutta-
rolo, F.; Tabrizi, M. A.; Romagnoli, R. Bioorg. Med.
Chem. 2007, 15, 17–35; (b) Baraldi, P. G.; Zaid, A. N.;
Preti, D.; Fruttarolo, F.; Tabrizi, M. A.; Iaconinoto, A.;
Pavani, M. G.; Carrion, M. D.; Cara, C. L.; Romagnoli, R.
Arkivoc 2006, 7, 20–34; (c) Broggini, M.; Marchini, S.;
Fontana, E.; Moneta, D.; Fowst, C.; Geroni, C. Anti-cancer
Drugs 2004, 15, 1–6; (d) Baraldi, P. G.; Nuˆnez, M. D. C.;
Espinosa, A.; Romagnoli, R. Curr. Top. Med. Chem. 2004,
4, 231–239; (e) Neamati, N.; Mazumder, A.; Sunder, S.;
Owen, J. M.; Tandon, M.; Lown, J. W.; Pommier, Y. Mol.
Pharmacol. 1998, 54, 280–290.
3. (a) Roy, S.; Gribble, G. W. Heterocycles 2006, 70, 51–56;
(b) Roy, S.; Roy, S.; Gribble, G. W. Tetrahedron Lett.,
submitted for publication.
4. (a) Smith, H. A.; Bedoit, W. C., Jr. Catalysis 1955, 3, 149–
170; (b) Downing, R. S.; Kunkeler, P. J.; van Bekkum, H.
Catal. Today 1997, 37, 121; (c) Figueras, F.; Coq, B. J. Mol.
Catal. A: Chem. 2001, 173, 223–230.
1
Compound 4a: yellow solid (solid upon staying); H NMR
(CDCl3): d 7.27 (br s, 1H), 7.15 (t, 1H), 6.42 (t, 1H), 5.92
(dd, 1H), 3.60 (s, 3H), 2.29 (t, 2H, J = 7.6 Hz), 1.70 (m,
2H), 1.33 (m, 4H), 0.90 (t, 3H, J = 7.0 Hz); 13C NMR
(CDCl3): d 170.4, 122.8, 119.7, 113.2, 100.5, 37.2, 36.7, 31.7,
25.8, 22.7, 14.2; MS (EI): m/z (%) = 194 ([M+]), 156, 138,
123, 112, 96 (100), 81, 68, 57; HRMS (EI): m/z calcd for
C11H18ON2: 194.1419. Found: 194.1420.
1
Compound 4b: Brown oil; H NMR (CDCl3): d 7.89 (br s,
1H), 7.81–7.82 (m, 2H), 7.66 (dd, 1H), 7.42–7.56 (m, 3H),
7.03 (dd, 1H), 6.18 (dd, 1H), 2.26 (t, 2H, J = 7.6 Hz), 1.59–
1.65 (m, 2H), 1.22–1.28 (m, 4H), 0.84 (t, 3H, J = 6.8 Hz);
13C NMR (CDCl3): d 171.3, 138.8, 134.1, 129.6, 127.3,
127.1, 119.8, 109.8, 107.8, 36.9, 31.6, 25.5, 22.6, 14.1; MS
(EI): m/z (%) = 320 ([M+]), 277, 264, 238, 222 (100), 179,
157, 141, 126, 99, 81; HRMS (EI): m/z calcd for
C16H20N2O3S: 320.1195. Found: 320.1190.
Compound 5a: white solid; mp 88–89 °C; 1H NMR
(CDCl3): d 6.84 (m, 1H), 6.41 (t, 1H), 6.27 (br s, 1H),
5.88 (m, 1H), 3.59 (s, 3H), 1.50 (s, 9H); 13C NMR (CDCl3):
d 153.6, 123.0, 120.0, 111.8, 100.7, 79.9, 36.7, 28.7; MS (EI):
m/z (%) = 196 ([M+]), 153, 140 (100), 123, 96, 81, 68, 57;
HRMS (EI): m/z calcd for C10H16O2N2: 196.1212. Found:
196.1213.
5. (a) De Rosa, M.; Stepani, N.; Cole, T.; Fried, J.; Huang-
Pang, L.; Peacock, L.; Pro, M. Tetrahedron Lett. 2005, 46,
5715–5717; (b) De Rosa, M.; Sellitto, L.; Issac, R. P.;
Ralph, J.; Timken, M. D. J. Chem. Res. (S) 1999, 262–
263.
6. Fu, L.; Gribble, G. W. Synthesis, submitted for publication.
7. Representative procedure (2a): To a solution of 1-methyl-3-
nitropyrrole (1a) (32 mg, 0.25 mmol) and acetic anhydride
(77 mg, 0.75 mmol) in anhydrous methanol (3 mL) was
added 10% palladium on carbon (10 mg). The atmosphere
of the flask was replaced by hydrogen gas and the reaction
was cooled to À78 °C. After three vacuum/hydrogen cycles
to remove air from the reaction flask, the reaction mixture
was heated to 60 °C under atmospheric pressure for 2.5 h,
having the hydrogen atmosphere maintained by a balloon.
The catalyst was removed by filtration through Celite. The
filtrate was evaporated and the crude product was purified
by column chromatography (Hex/EtOAc = 2:1) to give the
desired product (2a) (32 mg, 91%) as a yellow solid: mp
121–122 °C (lit.1a mp 120.5–121 °C); 1H NMR (acetone-d6):
d 9.01 (br s, 1H), 7.10 (t, 1H), 6.47 (t, 1H), 5.93 (dd, 1H),
3.61 (s, 3H), 2.02 (s, 3H); 13C NMR (acetone-d6): d 166.1,
124.2, 119.3, 112.1, 100.0, 35.6, 22.6.
Compound 5b: white solid; mp 172–173 °C; 1H NMR
(CDCl3): d 7.86 (m, 2H), 7.58 (m, 1H), 7.48 (m, 2H), 7.35
(br s, 1H), 7.05 (t, 1H), 6.34 (m, 1H), 6.14 (m, 1H), 1.48 (s,
9H); 13C NMR (CDCl3): d 152.7, 139.1, 134.0, 129.5, 128.1,
127.8, 127.1, 120.1, 107.9, 80.8, 28.5; MS (EI): m/z
(%) = 322 ([M+]), 266 (100), 248, 222, 191, 158, 141, 125,
108, 77; HRMS (EI): m/z calcd for C15H18O4N2S: 322.0987.
Found: 322.0988.
Compound 6a: white solid; mp 99.5–101 °C; 1H NMR
(acetone-d6): d 7.11 (m, 1H), 6.61 (m, 1H), 6.48 (m, 1H),
3.68 (s, 3H), 2.77 (s, 4H); 13C NMR (acetone-d6): d 176.0,
119.9, 117.9, 115.6, 103.3, 35.8, 28.1; Anal. Calcd for
C9H10N2O2: C, 60.66; H, 5.66; N, 15.72. Found: C, 60.62;
H, 5.66; N, 15.71.
Compound 6b: white solid; mp 161–162 °C; 1H NMR
(acetone-d6): d 8.02 (m, 2H), 7.77–7.80 (m, 2H), 7.67 (m,
2H), 7.34 (dd, 1H), 6.99 (dd), 2.82 (s, 4H); 13C NMR
(acetone-d6): d 175.8, 138.9, 134.8, 130.1, 127.2, 123.1,
119.6, 112.8, 109.0, 28.2; Anal. Calcd for C14H12N2O4S: C,
55.26; H, 3.97; N, 9.16; S, 10.59. Found: C, 55.00; H, 4.16;
N, 9.16; S, 10.59.
8. Compound 2b: White solid; mp 169–170.5 °C; 1H NMR
(acetone-d6): d 9.27 (br s, 1H), 7.94–7.97 (m, 2H), 7.71–7.74
(m, 1H), 7.69 (t, 1H), 7.62–7.66 (m, 2H), 7.18 (dd, 1H), 6.27
(dd, 1H), 2.01 (s, 3H); 13C NMR (acetone-d6): d 167.8,
139.8, 134.9, 130.4, 129.1, 127.6, 120.5, 109.6, 108.5, 23.1;
Anal. Calcd for C12H12N2O3S: C, 54.53; H, 4.58; N, 10.60;
S, 12.13. Found: C, 54.36; H, 4.49; N, 10.49; S, 12.05.
Compound 2d: white solid; mp 128–129 °C; 1H NMR
(CDCl3): d 8.57 (br s, 1H), 7.74–7.76 (m, 2H), 7.62 (m,
2H), 7.52 (m, 2H), 6.90 (dd, 1H), 6.55 (t, 1H), 6.24 (t, 1H),
2.18 (s, 3H); 13C NMR (CDCl3): d 166.8, 138.5, 134.6,
130.0, 128.6, 126.8, 116.7, 113.1, 104.0, 24.3; Anal.
Compound 6c: white solid; mp 166–167 °C (lit.9 mp 163–
1
164 °C); H NMR (acetone-d6): d 6.72 (dd, 1H), 6.05 (dd,
1H), 5.93 (dd, 1H), 3.41 (s, 3H), 2.89 (s, 4H); 13C NMR
(acetone-d6): d 176.8, 121.5, 120.6, 106.7, 106.4, 32.4,
28.5.
Compound 7a: yellow solid; mp 172.5–174 °C; 1H NMR
(CDCl3): d 7.73–7.91 (m, 4H), 7.07 (t, 1H), 6.63 (t, 1H),
6.53 (dd, 1H), 3.71 (s, 3H); 13C NMR (CDCl3): d 167.5,